Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | +4.72% | +4.72% | -23.99% |
05-31 | Piper Sandler Starts Allogene Therapeutics With Overweight Rating, $11 Price Target | MT |
05-21 | Oppenheimer Trims Allogene Therapeutics Price Target to $13 From $14, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.99% | 486M | |
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- ALLO Stock
- News Allogene Therapeutics, Inc.
- Allogene Therapeutics : Jefferies Starts Allogene Therapeutics at Buy with $53 Price Target